Screener
West Pharmaceutical Services WST Q1 2026 earnings
Reported April 23, 2026 · Before market open
Revenue$844.9MBeat by $64.6M
EPS$2.13Beat by $0.45
Revenue estimate$780.3M
EPS estimate$1.68
Next report
Oct 22, 2026 (in 2 months)Revenue estimate$825.9M
EPS estimate$2.18
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did West Pharmaceutical Services report Q1 2026 earnings?
- West Pharmaceutical Services (WST) reported Q1 2026 earnings on April 23, 2026 before market open.
- What were West Pharmaceutical Services's Q1 2026 revenue and EPS?
- West Pharmaceutical Services reported revenue of $844.9M and eps of $2.13 for Q1 2026.
- Did West Pharmaceutical Services beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $780.3M by $64.6M. EPS beat the consensus estimate of $1.68 by $0.45.
- How did West Pharmaceutical Services's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 21.0% from $698.0M a year earlier and eps grew 46.9% from $1.45.
- Where can I find West Pharmaceutical Services's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0000105770-26-000047) and the 10-Q periodic report (0000105770-26-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.
